UPDATE : Monday, September 7, 2020
상단여백
Bridge Biotherapeutics passes preliminary review for Kosdaq listing
Bridge Biotherapeutics has passed the regulatory agency’s preliminary revie...
by Jeong Sae-im  |  2019-10-25 15:05
라인
KangStem Biotech fails in phase-3 study on atopic dermatitis drug
KangStem Biotech said it has failed to prove the efficacy of Furestem-AD, a...
by Jeong Sae-im  |  2019-10-25 11:17
라인
Value assessment on anticancer drugs hotly discussed
Experts are raising the need to establish tools to calculate the value of n...
by Jeong Sae-im  |  2019-10-24 13:46
라인
PharmAbcine sets up US unit to develop anticancer drug
PharmAbcine said it would speed up the development of a new anticancer drug...
by Jeong Sae-im  |  2019-10-23 15:48
라인
‘Oral drugs as effective as inhalers for elderly with asthma’
Physicians generally recommend inhaled corticosteroids as the first drug fo...
by Jeong Sae-im  |  2019-10-22 15:48
라인
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
Dong-A ST is voluntarily giving up its membership of the Korea Pharmaceutic...
by Jeong Sae-im  |  2019-10-21 16:42
라인
Drug firms’ Q3 earnings to be fairly good
Korea’s large pharmaceutical companies are expected to have yielded good ea...
by Jeong Sae-im  |  2019-10-21 12:27
라인
Medytox exported ￦3.3 billion worth of unqualified BTX
The Ministry of Food and Drug Safety ordered Medytox to recall and discard ...
by Jeong Sae-im  |  2019-10-18 16:02
라인
US sales of Remicade drop due to biosimilar’s rise
U.S. sales of Remicade (ingredient: infliximab), the autoimmune disease tre...
by Jeong Sae-im  |  2019-10-17 13:32
라인
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
The Samsung Group has admitted that a Samsung-affiliated company failed to ...
by Jeong Sae-im  |  2019-10-16 14:16
라인
Kolon Life Science shares surge after TissueGene’s survival
Shares of Kolon Life Science shot up after the regulator decided to delay t...
by Jeong Sae-im  |  2019-10-14 18:01
라인
HLB merges with Elevar to own rivoceranib rights
HLB said it would merge with its subsidiary Elevar, a U.S.-based developer ...
by Jeong Sae-im  |  2019-10-14 14:43
라인
‘Kosdaq firms listed for exceptional tech need special monitoring’
About 80 percent of companies listed on the Kosdaq stock market using the r...
by Jeong Sae-im  |  2019-10-07 15:51
라인
Samsung execs pass buck to biotech subsidiaries for destroying evidence
Samsung executives said Samsung BioLogics and Samsung Bioepis workers were ...
by Jeong Sae-im  |  2019-10-04 11:42
라인
Regulator raids cell therapy makers too often to little avail
In the wake of the recall of cell gene therapy Invossa-K, the Ministry of F...
by Jeong Sae-im  |  2019-10-02 11:23
라인
Will parliamentary audit uncover why Invossa was mislabeled?
The National Assembly’s Health and Welfare Committee is expected to focus o...
by Jeong Sae-im  |  2019-10-01 15:45
라인
Ranitidine recall taking heavy toll on pharmaceuticals
Pharmaceutical companies are expected to suffer massive losses due to the r...
by Jeong Sae-im  |  2019-09-30 15:16
라인
Regulator explained why it banned stomach medicine ranitidine altogether
The Ministry of Food and Drug Safety Thursday offered a briefing to pharmac...
by Jeong Sae-im  |  2019-09-27 15:02
라인
‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’
Executives of Samsung BioLogics and affiliated companies claimed that they ...
by Jeong Sae-im  |  2019-09-26 15:24
라인
Helixmith blames hospital for absurd drug mix-up
Helixmith used to be one of the promising biotech firms with its market cap...
by Jeong Sae-im  |  2019-09-25 13:42
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top